Saturday 17 October 2026 Export SNOA’s income statement to Excel — free account

Sonoma Pharmaceuticals, Inc.

SNOA Healthcare Drug Manufacturers Specialty & Generic

Sonoma Pharmaceuticals, Inc.’s revenue for fiscal 2026 (year ended March 2026) was $19.5 million, up 36.7% from fiscal 2025. In the quarter to June 2026, revenue grew 59.6%, EPS grew 88.2% and free cash flow grew 69.3%, each against the same quarter a year earlier.

1.13 0.02 −1.74%

Follow SNOA

Alert me

Market cap: $5.5M
P/E: 0.0×
Fwd P/E: −2.0×
Dividend yield: —
F-score: 3/9
Altman Z: −18.52
Beneish M: −1.69
Dividend safety: n/a

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

	Jun '26	Mar '26	Dec '25	Sep '25	Older periods
ROE Full definition →	(42.52%)	(84.60%)	(81.19%)	(76.14%)	+8 more TTM periods Free account
Piotroski F-Score Full definition →	5	3	4	4
ROA Full definition →	(13.85%)	(22.96%)	(24.70%)	(25.26%)
ROIC Full definition →	(69.96%)	(220.99%)	(198.48%)	(259.23%)
Return on Tangible Assets Full definition →	(20.38%)	(41.90%)	(40.89%)	(41.11%)
Average Days of Receivables Full definition →	52.98	47.23	49.06	58.25
Free Cash Flow per Share Full definition →	(0.69)	(2.45)	(2.17)	(1.42)
Free Cash Flow Full definition →	(2.65)	(4.12)	(3.72)	(2.34)
Capital Expenditures Full definition →	(0.09)	(0.19)	(0.21)	(0.16)
Other line items
Cash ROIC Full definition →	(22.25%)	(75.08%)	(62.06%)	(34.37%)
Accounts Receivable Turnover Full definition →	7.58	8.21	7.40	5.78
Accounts Payable Turnover Full definition →	6.32	8.42	7.21	9.71
Inventory Turnover Full definition →	3.53	3.69	3.20	3.26
Average Days of Payables Full definition →	59.72	57.94	54.82	48.55
Days of Inventory on Hand Full definition →	103.19	110.01	123.32	125.67
Tax Rate Full definition →	0.00	(0.07)	(0.02)	0.02
Research and Development Expense of Revenue Full definition →	10.37%	11.63%	12.06%	11.85%
Selling, General and Administrative Expense of Revenue Full definition →	34.95%	38.94%	41.71%	44.25%
Share Based Compensation of Revenue Full definition →	1.17%	1.31%	1.18%	1.17%
Operating CF/Net income Full definition →	1.13	1.24	1.04	0.63
Depreciation/Fixed assets Full definition →	0.47	0.45	0.44	0.48
Capex/Depreciation Full definition →	(0.65)	(1.38)	(1.53)	(1.21)
Revenue per Share Full definition →	5.70	11.60	10.35	10.29
Operating CF per Share Full definition →	(0.67)	(2.34)	(2.05)	(1.32)
Capex per Share Full definition →	(0.02)	(0.11)	(0.12)	(0.10)
Capex to Sales Full definition →	0.00	0.01	0.01	0.01

Fold the line items

Columns are period end dates

Stockrow Weekly